BioMind
PrivateLast Round
Series B
Aug 1, 2021
Est. Valuation
$500M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioMind is a healthtech company that develops artificial intelligence-based medical imaging diagnostic software to assist physicians in identifying and analyzing medical conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioMind Comparables
Compare BioMind with similar companies based on industry and business-model similarity.
BioMind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 1, 2021 | ||||
| Series A Extension | Nov 1, 2020 | ||||
| Series A | Aug 1, 2019 | ||||
| Angel | Nov 1, 2018 |
BioMind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Power Capital | Series A Extension |
| China Science and Technology Industry Investment Management | Series B |
| Tianfeng Tianrui Investment | Series A Extension |
| Bosera Asset Management | Series A Extension |
| Green Harbor Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 264% MoM, reaching 3K.
- Oct 30, 2024
Monthly visitors grew 153% MoM.
BioMind Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioMind's valuation, stock price, and market status.
Is BioMind a public or private company?
BioMind is a private company.
What is the current stock price of BioMind?
BioMind is a private company with no public stock price. No recent secondary market data is available.
How much is BioMind worth (valuation)?
BioMind's valuation is estimated at $500.0M based on funding round data.
Can I buy BioMind stock?
BioMind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioMind's last funding round?
BioMind's most recent funding round was Series B on August 1, 2019.
Who are the main investors in BioMind?
Key investors in BioMind include Power Capital, China Science and Technology Industry Investment Management, Tianfeng Tianrui Investment, Bosera Asset Management, Green Harbor Investment.
Will BioMind IPO soon?
No public IPO plans have been announced for BioMind.
How can I track BioMind secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioMind's secondary market activity and sign up for updates.